‘This Covid-19 epidemic is turning into a flu’

By RFI

Dado el corto recorrido que tienen las vacunas anti Covid-19, aun se desconoce durant cuanto tiempo protegen. For weeks, months, years? The boss of the pharmaceutical company Pfizer, Albert Bourla, has sent a few dudas to affirm that after receiving a third dose, the person can vaccinate one vez per year.

The director of the Canadian pharmaceutical giant is very optimistic. Make sure the most likely scenario is that the Covid-19 epidemic transforms, over time, into a virus like the flu, in an interview with the NBC television channel.

For this, it is stated that the persons who have received the dose, tend to repeat the injection in 6 or 12 months and lie down to wake up one year to the next. “A probable hypothesis is that a third dose is necessary“I’re part of ahí habrá that volver a vacunar cada ano, pero todo eso tiene que confirmmarse”, dijo Bourla.

Something similar to what happens to the flu, many people are evacuated annually. “We will feel like the flu, we will be evacuated annually and we will have a normal life,” he said.

The example of Israel

This optimist is also known to prevail that we can return to a normal life before the end of the year. And as an example in the case of Israel, the massive evacuation is very likely to have left the home and there is no obligation to leave the mascara free. More than 53% of the Israeli population have received Pfizer doses.

To reach the Israeli level on a global level, many vacancies are needed. Bourla promises thousands of doses in the next months. Pfizer and its German company BioNTech claim that they are pursuing the career of the anti-Covid business with ARN Messenger technology, which has never been used before.

At least in Europe, after failing to enter the vacancies on the part of the Anglo-Saxon AstraZeneca, it was heavily affected by the vacancies. “It is a credible society, which has complied with its compromises and has reacted to the needs,” said European Commission President Ursula von der Leyen.

The inconsistency of the variants

Destruction insurance very confirmed by confirmed, for a load the exact duration of the protection and for another, if this vaccine is effective against the more contagious variants, such as the British or the Brazilian.

Between the scientific community of Todavia no hay consensus on Pfizer efficiency against the variant and the same Bourla recognizes that there is an agreement to resolve. “Las variants jugarán un papel fundamental”, declared.

By RFI

Dado el corto recorrido que tienen las vacunas anti Covid-19, aún se desconoce durant quianto tempote protegen. For weeks, months, years? The boss of the pharmaceutical company Pfizer, Albert Bourla, has sent a few dudas to affirm that after receiving a third dose, the person can vaccinate one vez per year.

The director of the Canadian pharmaceutical giant is very optimistic. Make sure the most likely scenario is that the Covid-19 epidemic transforms, over time, into a virus like the flu, in an interview with the NBC television channel.

For this, it is stated that the persons who have received the dose, tend to repeat the injection in 6 or 12 months and lie down to wake up one year to the next. “A probable hypothesis is that a third dose is required“I’re part of ahí habrá that volver a vacunar cada ano, pero todo eso tiene que confirmmarse”, dijo Bourla.

Something similar to what happens to the flu, many people are evacuated annually. “We will feel like the flu, we will be evacuated annually and we will have a normal life,” he said.

The example of Israel

This optimist is also known to prevail that we can return to a normal life before the end of the year. And as an example in the case of Israel, the massive evacuation has made it possible that part of the domingo is not obligated to wear free mascara. More than 53% of the Israeli population have received Pfizer doses.

To reach the Israeli level on a global level, many vacancies are needed. Bourla promises thousands of doses in the next months. Pfizer and its German company BioNTech claim that they are pursuing the career of the anti-Covid business with ARN Messenger technology, which has never been used before.

At least in Europe, after failing to enter the vacancies on the part of the Anglo-Saxon AstraZeneca, it was heavily affected by the vacancies. “It is a credible society, which has complied with its compromises and has reacted to the needs,” said European Commission President Ursula von der Leyen.

The inconsistency of the variants

Destruction insurance very confirmed by confirmed, for a load the exact duration of the protection and for another, if this vaccine is effective against the more contagious variants, such as the British or the Brazilian.

Between the scientific community todavia no hay consensus on Pfizer efficiency against the variant and the same Bourla recognizes that there is an agreement to resolve. “Las variants jugarán un papel fundamental”, declared.

;